There is continuous progress in systems medicine, multi-scale modelling and patient-specific modelling aspects. But these opportunities have been inconstantly explored for the entire chain of health and disease. Thus, there are very few in well-being, prevention or rehabilitation while these areas are crucial for reducing healthcare needs, building sustainable healthcare and for assuring a healthy and motivated workforce.

The use of interoperability standards is essential to the wider deployment of an EU eHealth single market. Despite previous Framework Programmes investments, there is still a profound lack of deployed interoperability between healthcare systems and services delivering healthcare and a need to stimulate the public procurement of eHealth solutions and integrated care services addressing complex organisational structures and interactions among people (recipients of care, care-givers, and others).

This topic will be developed during the course of 2016.

Despite serious efforts deployed at national and European level, the European Union sees significant internal disparities in terms of research and innovation performance as also identified in the Innovation Union Scoreboard. The disparities are equally present in health research and innovation and this call seeks solutions specifically adapted to this domain.The European Commission has been funding projects to analyse the roots of the divide in European health research and innovation (HCO-14 2014) and wishes to continue efforts in closing the gap.

Topic details will be developed in line with the timetable of the GACD priority setting process and will be provided during the course of 2016.

y providing the right intervention to the right person at the right time, personalised medicine[1] can improve quality of life and contribute to more sustainable healthcare at Member State level. It may drive new and faster development processes and products, providing European life sciences industries with a competitive edge that can secure growth and jobs.